[[12, 36, [[6, 762, "Table 3. 6,7-Dihydro-5H-pyrazoloS,1-b 1,3oxazine"]]], [49, 73, [[3, 186, "Substitutions"]]], [288, 319, [[389, 405, "ZI"]]], [360, 421, [[27, 156, "Compound"], [257, 292, "R3"], [423, 545, "IL-1\u03b2 IC5o (uM)c"], [628, 710, "cLogP cLogD"], [762, 830, "LLEd"]]], [451, 516, [[27, 155, "GDC-2394 (20)"], [261, 288, "H N"], [398, 569, "0.0054  0.004 (n=16)"], [648, 689, "1.1 0.1"], [775, 817, "8.2"]]], [563, 623, [[60, 122, "R-20"], [458, 512, "1.40"], [648, 689, "1.1 0.1"], [775, 817, "5.8"]]], [673, 741, [[69, 113, "21a"], [404, 562, "0.013  0.008 (n=3)"], [647, 691, "1.6 0.4"], [775, 818, "7.5"]]], [766, 853, [[69, 112, "22a"], [206, 264, "MeO"], [412, 554, "0.012  0.01 (n=3)"], [648, 690, "1.2 0.1"], [775, 817, "7.8"]]], [900, 961, [[69, 112, "23b"], [455, 512, "2.40"], [646, 694, "1.7 -0.1"], [774, 818, "5.7"]]], [1006, 1034, [[8, 845, "Data reported for the most potent stereoisomer. bTested as ths"]]], [1048, 1072, [[6, 846, "acemate. Inhibition of the NLRP3 inflammasome pathway wa"]]], [1087, 1107, [[6, 848, "assessed by quantifying lL-l\u03b2 release from LPS + nigericin stimulatec"]]], [1120, 1143, [[6, 848, "PBMCs (reported as geometric mean t SD; compounds R-20 anc"]]], [1151, 1183, [[5, 850, "23 are reported as n = 1). aLLE was calculated using the following"]]], [1189, 1215, [[9, 494, "quation: LLE = pICso IL-1\u03b2 - cLogD"]]]]